Re: Berenson J, Hirschberg R. Safety and convenience of a 15-minute infusion of zoledronic acid.
Diel
Ingo J
IJ
Bergner
Raoul
R
D001859:Bone Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000556:secondary; D003404:Creatinine / Q000097:blood; D004164:Diphosphonates / Q000008:administration & dosage* / Q000009:adverse effects*; D006207:Half-Life; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology; D007093:Imidazoles / Q000008:administration & dosage* / Q000009:adverse effects*; D007262:Infusions, Intravenous; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D012449:Safety; D000077211:Zoledronic Acid
D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid; D003404:Creatinine